Aloe-derived polysaccharides (APS) mitigate SARS-CoV-2 Omicron BQ1.1 infection by preserving epithelial integrity and reducing viral load in human airway epithelial (HAE) cultures

Aloe-derived polysaccharides (APS)
APS demonstrates inhibitory effects against the SARS-CoV-2 Omicron variant BQ.1.1, effectively reducing viral replication and alleviating virus-induced cellular damage, highlighting its potential as a natural adjunct for antiviral therapy.